{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:04:54Z","timestamp":1753891494518,"version":"3.41.2"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T00:00:00Z","timestamp":1629849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Biosci."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> MicroRNAs have been linked to angiogenesis and could prove to be valuable future therapeutic targets in ischemic cardiovascular diseases.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Ten-week-old male C57Bl\/6 mice were subjected to left femoral artery ligation and were treated with microRNA-126 mimic at a dose of 5\u00a0mg\/kg (Group A, <jats:italic>n<\/jats:italic> = 10) or 5\u00a0mg\/kg microRNA mimic negative control (Group B, <jats:italic>n<\/jats:italic> = 10) on days 1, 3, and 7. Laser Doppler imaging was performed to verify successful ligation on day 0 and to evaluate differences in the ischemic-to-normal (I\/N) hind limb perfusion ratio on day 28. Muscle tissue expression of microRNA-126 and vascular endothelial growth factor (VEGF) was determined <jats:italic>via<\/jats:italic> PCR.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Following microRNA-126 mimic administration in Group A subjects, we noted a stepwise increase in I\/N hind limb perfusion ratio (Day 0: 0.364 \u00b1 0.032 vs. Day 8: 0.788 \u00b1 0.049 vs. Day 28: 0.750 \u00b1 0.039, <jats:italic>p<\/jats:italic> = 0.001). In Group B a stepwise increase in I\/N hind limb perfusion ratio was observed (Day 0: 0.272 \u00b1 0.057 vs. Day 8: 0.382 \u00b1 0.020 vs. Day 28: 0.542 \u00b1 0.028, <jats:italic>p<\/jats:italic> = 0.074). Muscle tissue expression of microRNA-126 in the ischemic hind limb of Group A was 350-fold lower compared to the ischemic hind limb of Group B (<jats:italic>p<\/jats:italic> &amp;lt; 0.001). A higher expression (14.2-fold) of VEGF in the ischemic hind limb of microRNA-126-treated mice compared to that of control group was detected (<jats:italic>p<\/jats:italic> &amp;lt; 0.001). A statistically significant negative correlation was noted between microRNA-126 and VEGF tissue expression levels in the ischemic limbs of the entire study population.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> MicroRNA-126 delivery in the ischemic hind limb of mice improved vascular perfusion with VEGF upregulation.<\/jats:p>","DOI":"10.3389\/fmolb.2021.724465","type":"journal-article","created":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T04:46:36Z","timestamp":1629866796000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["The Effect of MicroRNA-126 Mimic Administration on Vascular Perfusion Recovery in an Animal Model of Hind Limb Ischemia"],"prefix":"10.3389","volume":"8","author":[{"given":"Panagiotis","family":"Theofilis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgia","family":"Vogiatzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evangelos","family":"Oikonomou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Gazouli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerasimos","family":"Siasos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hector","family":"Katifelis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Despoina","family":"Perrea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manolis","family":"Vavuranakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios C","family":"Iliopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Costas","family":"Tsioufis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitris","family":"Tousoulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,8,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","article-title":"2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in Collaboration with the European Society for Vascular Surgery (ESVS): Document Covering Atherosclerotic Disease of Extracranial Carotid and Vertebral, Mesenteric, Renal, Upper and Lower Extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS)","volume":"39","author":"Aboyans","year":"2018","journal-title":"Eur. Heart J."},{"key":"B2","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s12265-020-10066-9","article-title":"Double VEGF\/HGF Gene Therapy in Critical Limb Ischemia Complicated by Diabetes Mellitus","volume":"14","author":"Barc","year":"2020","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.ymthe.2016.12.022","article-title":"Human Pericardial Fluid Contains Exosomes Enriched with Cardiovascular-Expressed MicroRNAs and Promotes Therapeutic Angiogenesis","volume":"25","author":"Beltrami","year":"2017","journal-title":"Mol. Ther."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1126\/science.1174381","article-title":"MicroRNA-92a Controls Angiogenesis and Functional Recovery of Ischemic Tissues in Mice","volume":"324","author":"Bonauer","year":"2009","journal-title":"Science"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1161\/atvbaha.115.306506","article-title":"Therapeutic Angiogenesis by Ultrasound-Mediated MicroRNA-126-3p Delivery","volume":"35","author":"Cao","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"101607","DOI":"10.1016\/j.redox.2020.101607","article-title":"MicroRNAs in the Regulation of Cellular Redox Status and its Implications in Myocardial Ischemia-Reperfusion Injury","volume":"36","author":"Carbonell","year":"2020","journal-title":"Redox Biol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/j.biocel.2009.12.014","article-title":"MicroRNAs: Potential Biomarkers for Cancer Diagnosis, Prognosis and Targets for Therapy","volume":"42","author":"Cho","year":"2010","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1161\/atvbaha.110.206201","article-title":"microRNA-222 Controls Neovascularization by Regulating Signal Transducer and Activator of Transcription 5A Expression","volume":"30","author":"Dentelli","year":"2010","journal-title":"Atvb"},{"key":"B9","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1161\/atvbaha.117.309189","article-title":"MicroRNA-150 Modulates Ischemia-Induced Neovascularization in Atherosclerotic Conditions","volume":"37","author":"Desjarlais","year":"2017","journal-title":"Atvb"},{"key":"B10","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.atherosclerosis.2015.06.037","article-title":"The Role of microRNAs in Coronary Artery Disease: From Pathophysiology to Diagnosis and Treatment","volume":"241","author":"Economou","year":"2015","journal-title":"Atherosclerosis"},{"key":"B11","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.devcel.2008.07.008","article-title":"miR-126 Regulates Angiogenic Signaling and Vascular Integrity","volume":"15","author":"Fish","year":"2008","journal-title":"Dev. Cell"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3390\/cells8020121","article-title":"Micrornas at the Interface between Osteogenesis and Angiogenesis as Targets for Bone Regeneration","volume":"8","author":"Fr\u00f6hlich","year":"2019","journal-title":"Cells"},{"key":"B13","doi-asserted-by":"publisher","first-page":"241","DOI":"10.4161\/org.4.4.7414","article-title":"VEGF and Endothelial Guidance in Angiogenic Sprouting","volume":"4","author":"Gerhardt","year":"2008","journal-title":"Organogenesis"},{"key":"B14","doi-asserted-by":"publisher","first-page":"111279","DOI":"10.1016\/j.biopha.2021.111279","article-title":"The Emerging Role of Non-coding RNAs in the Regulation of PI3K\/AKT Pathway in the Carcinogenesis Process","volume":"137","author":"Ghafouri-Fard","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"B15","doi-asserted-by":"publisher","first-page":"579892","DOI":"10.3389\/fphys.2020.579892","article-title":"Extracellular Vesicle miRNAs in the Promotion of Cardiac Neovascularisation","volume":"11","author":"Kesidou","year":"2020","journal-title":"Front. Physiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2\u2212\u0394\u0394CT Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"B17","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/s41569-019-0218-x","article-title":"RNA-based Diagnostic and Therapeutic Strategies for Cardiovascular Disease","volume":"16","author":"Lu","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"3290372","DOI":"10.1155\/2018\/3290372","article-title":"MicroRNA-132, Delivered by Mesenchymal Stem Cell-Derived Exosomes, Promote Angiogenesis in Myocardial Infarction","volume":"2018","author":"Ma","year":"2018","journal-title":"Stem Cell Int."},{"key":"B19","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/s1044-579x(03)00038-5","article-title":"MicroRNAs and Cancer","volume":"13","author":"McManus","year":"2003","journal-title":"Semin. Cancer Biol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e009724","DOI":"10.1161\/JAHA.118.009724","article-title":"Determinants of Long-Term Outcomes and Costs in the Management of Critical Limb Ischemia: A Population-Based Cohort Study","volume":"7","author":"Mustapha","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1016\/j.clnu.2019.12.028","article-title":"Vitamin D: A Magic Bullet or a Myth?","volume":"39","author":"Reijven","year":"2020","journal-title":"Clin. Nutr."},{"key":"B22","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1093\/cvr\/cvq045","article-title":"Hypoxia-inducible Factor-1-dependent Mechanisms of Vascularization and Vascular Remodelling","volume":"86","author":"Rey","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"pdb prot5439","DOI":"10.1101\/pdb.prot5439","article-title":"Purification of RNA Using TRIzol (TRI Reagent)","volume":"2010","author":"Rio","year":"2010","journal-title":"Cold Spring Harb. Protoc."},{"key":"B24","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.hjc.2020.03.003","article-title":"MicroRNAs in Cardiovascular Disease","volume":"61","author":"Siasos","year":"2020","journal-title":"Hellenic J. Cardiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1586\/14779072.2014.890516","article-title":"Novel Biomarkers in Heart Failure: Usefulness in Clinical Practice","volume":"12","author":"Siasos","year":"2014","journal-title":"Expert Rev. Cardiovasc. Ther."},{"key":"B26","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1182\/blood-2013-02-478925","article-title":"Endothelial Cells Require miR-214 to Secrete Exosomes that Suppress Senescence and Induce Angiogenesis in Human and Mouse Endothelial Cells","volume":"121","author":"van Balkom","year":"2013","journal-title":"Blood"},{"key":"B27","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.coph.2018.04.001","article-title":"Peripheral Artery Disease: a Micro-RNA-related Condition?","volume":"39","author":"Vogiatzi","year":"2018","journal-title":"Curr. Opin. Pharmacol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1111\/jcmm.16192","article-title":"Exosomes from microRNA-126 Overexpressing Mesenchymal Stem Cells Promote Angiogenesis by Targeting the PIK3R2-Mediated PI3K\/Akt Signalling Pathway","volume":"25","author":"Zhang","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"616161","DOI":"10.3389\/fcell.2020.616161","article-title":"The Role of Exosomes and Exosomal MicroRNA in Cardiovascular Disease","volume":"8","author":"Zheng","year":"2020","journal-title":"Front. Cell Dev. Biol"}],"container-title":["Frontiers in Molecular Biosciences"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2021.724465\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T04:46:38Z","timestamp":1629866798000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2021.724465\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,25]]},"references-count":29,"alternative-id":["10.3389\/fmolb.2021.724465"],"URL":"https:\/\/doi.org\/10.3389\/fmolb.2021.724465","relation":{},"ISSN":["2296-889X"],"issn-type":[{"type":"electronic","value":"2296-889X"}],"subject":[],"published":{"date-parts":[[2021,8,25]]},"article-number":"724465"}}